tiprankstipranks
Trending News
More News >
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market

Catalyst Pharma (CPRX) Income Statement

Compare
2,490 Followers

Catalyst Pharma Income Statement

Last quarter (Q3 2025), Catalyst Pharma's total revenue was $148.39M, an increase of 15.31% from the same quarter last year. In Q3, Catalyst Pharma's net income was $52.78M. See Catalyst Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 491.73M$ 398.20M$ 214.20M$ 140.83M$ 119.07M
Gross Profit
$ 422.89M$ 346.24M$ 179.81M$ 118.95M$ 102.03M
Operating Expenses
$ 227.76M$ 259.43M$ 77.97M$ 66.56M$ 60.73M
Depreciation and Amortization
$ 37.77M$ 32.88M$ 1.24M$ 192.00K$ 92.00K
EBITDA
$ 232.90M$ 119.69M$ 103.08M$ 52.58M$ 41.40M
Operating Income
$ 195.12M$ 86.81M$ 101.84M$ 52.38M$ 41.30M
Other Income/Expenses
$ 21.14M$ 7.70M$ 2.88M$ 282.00K$ 587.00K
Pretax Income
$ 216.26M$ 94.51M$ 104.72M$ 52.67M$ 41.89M
Net Income
$ 163.89M$ 71.41M$ 83.08M$ 39.48M$ 74.98M
Per Share Metrics
Basic EPS
$ 1.38$ 0.67$ 0.80$ 0.38$ 0.72
Diluted EPS
$ 1.31$ 0.63$ 0.75$ 0.37$ 0.71
Weighted Average Shares Outstanding
118.46M 106.28M 103.37M 103.38M 103.51M
Weighted Average Shares Outstanding (Diluted)
124.94M 113.75M 111.38M 107.80M 106.24M
Currency in USD

Catalyst Pharma Earnings and Revenue History